Bill Chappell (via NPR:Health)
Three years ago, the cigarette giant acquired Vectura, a British pharmaceutical firm that makes asthma inhalers, raising health groups’ ire. Now, it’s selling the business for almost $200 million.(Image credit: Fabrice Coffrini)
Continue reading at NPR:Health »
